CYP 17.3% 30.5¢ cynata therapeutics limited

Ann: Encouraging Initial Data from CYP-006TK DFU Trial, page-24

  1. 7,482 Posts.
    lightbulb Created with Sketch. 6755
    Meanwhile in the real world, the news got some coverage today:

    "Of the estimated 537 million people worldwide who have diabetes, 19% to 34% will develop a diabetic foot ulcer (DFU) in their lifetime. Approximately 20% of people who develop a DFU will require lower-extremity amputation, either minor (below the ankle), major (above the ankle), or both."

    Yes. Quite.

    https://unauthorised investment advice/health/asx-health-stocks-recce-cynata-say-their-diabetic-foot-ulcer-trials-are-going-great-guns/

    "The analysis of the first 16 patients (n=8 per group) found that the median percentage reduction in wound surface area in the active CYP-006TK group after 10 weeks’ follow-up was 87.6%, compared to 51.1% in the control group."

    As said above, after another 5 patients enrolled, if similar results repeated across the full 30 patient trial, statistical confidence likely to be around the somewhat arbitrary 95% confidence level that investors look at as success in trials, for CYP-006TK vs the SOC control group.

    And for the lucky patients in the CYP-006TK group perhaps a future amputation of a limb avoided for 3 or 4 patients, for all the crap from the very poorly informed detractors above, from some simple maths.

 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
30.5¢
Change
0.045(17.3%)
Mkt cap ! $54.78M
Open High Low Value Volume
26.5¢ 31.5¢ 26.5¢ $35.96K 122.3K

Buyers (Bids)

No. Vol. Price($)
1 12995 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 10185 1
View Market Depth
Last trade - 15.59pm 18/06/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.